MBTPS1 and cancer: Given a well-established role of SphK/S1P signaling in cancer and other inflammatory diseases, small molecule inhibitors of SphKs, antagonists of S1P receptors, and S1P-blocking antibodies can serve as promising candidates in cancer therapeutics.